SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-037785
Filing Date
2022-12-06
Accepted
2022-12-06 16:51:28
Documents
1
Period of Report
2022-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4205
  Complete submission text file 0000899243-22-037785.txt   5820
Mailing Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135
Business Address 40 GUEST STREET SUITE 4410 BOSTON MA 02135 617-409-5300
YUMANITY THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MINERVA NEUROSCIENCES, INC. 1601 TRAPELO ROAD, SUITE 286 WALTHAM MA 02451
Business Address
Smith Devin Whittemore (Reporting) CIK: 0001747818 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37695 | Film No.: 221448280